FDA Approves Imatinib (Gleevec) for Pediatric ALL
The US Food and Drug Administration has approved imatinib (Gleevec) for the treatment of newly diagnosed Philadelphia chromosome–positive acute lymphoblastic leukemia (Ph+ ALL) in children.
Source: Cancer Network - Category: Cancer & Oncology Source Type: news
More News: Acute Leukemia | Acute Lymphoblastic Leukemia | Cancer | Cancer & Oncology | Children | Food and Drug Administration (FDA) | Gleevec | Leukemia | Pediatrics